ArunA Biomedical, Inc.
DESCRIPTION (provided by applicant): Currently, up to one billion people worldwide suffer from disabling neurodegenerative disorders, including traumatic injuries, stroke and diseases of the CNS such ...SBIR Phase I 2012 Department of Health and Human Services
The objective of this proposed project and the EPA Computational Toxicology program’s goals are aligned in assessing chemicals for potential risk to human health and the environment through the use ...SBIR Phase I 2013 Environmental Protection Agency
SUMMARY The overarching objective of this Phase I project is to determine the feasibility of developing both focused and broad toxicity metabolomic assays for three neural development associated windo ...SBIR Phase I 2013 Department of Health and Human Services
This Small Business Innovation Research (SBIR) Phase I project will address the demand for new and evolving approaches to alleviate shrinking drug pipelines and costly failed human safety trials and r ...SBIR Phase I 2013 National Science Foundation
There is unmet need for rapid, cost effective in vitro methods to identify chemicals that pose a hazard to the human brain. A number of in vitro assays utilizing primary cells have been tested in an e ...SBIR Phase II 2014 Environmental Protection Agency